Search company, investor...



Acquired | Acquired

Total Raised




About Bioness

Bioness offers medical devices designed to benefit people with stroke, Multiple Sclerosis, traumatic brain injury, Cerebral Palsy, and spinal cord injury. These products use electrical stimulation to help people regain mobility and independence, to improve quality of life and productivity.On March 31st, 2021, Bioness was acquired by Bioventus at a valuation between $45M and $110M.

Headquarters Location

25103 Rye Canyon Loop

Valencia, California, 91355,

United States


Missing: Bioness's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Bioness's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Bioness

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Bioness is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,648 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

Bioness Patents

Bioness has filed 1 patent.

The 3 most popular patent topics include:

  • Neurological disorders
  • Neurotrauma
  • Rehabilitation medicine
patents chart

Application Date

Grant Date


Related Topics




Neurotrauma, Neurological disorders, Rehabilitation medicine, Psychiatric diagnosis, Medical signs


Application Date


Grant Date



Related Topics

Neurotrauma, Neurological disorders, Rehabilitation medicine, Psychiatric diagnosis, Medical signs



Latest Bioness News

According to FMI, the global Motion stimulation therapy market SWOT Analysis, Growth Prospects and Rising Demand 2022-2032

Nov 10, 2022

Search jobs 10-Nov-2022 According to FMI, the global Motion stimulation therapy market SWOT Analysis, Growth Prospects and Rising Demand 2022-2032 Motion Stimulation Therapy Market Snapshot (2022 – 2032) Motion Stimulation Therapy is a type of physical therapy that is used after an event such as a stroke or spinal cord injury causes muscle denervation, paralysis, or weakness. Motion stimulation therapy helps to produce the voluntary forces needed for joint moments, allowing for the functional performance of daily tasks. Request a Sample Copy of this research: Motion Stimulation Therapy Market Size was valued at US$ 1.1 Million in FY 2021, and is projected to grow at a 9.1% Y-o-Y growth rate until 2022, reaching a market value of US$ 1.2 Million. During the forecast period ranging from 2022 to 2032, a CAGR of 4.1% is expected for the market, reaching US$ 1.8 Million. Muscle spasms, pain relief, and inflammation reduction can all benefit from motion stimulation therapy. Motion stimulation therapy also promotes muscle contraction, which aids in the prevention of muscle atrophy. Parkinson’s disease, a progressive neurodegenerative disorder that primarily affects the elderly, can benefit from motion stimulation therapy. Report Attribute 4.1% CAGR Deep brain stimulation (DBS) is a type of movement stimulation therapy used to treat Parkinson’s disease. Deep brain stimulation is the most commonly used surgical treatment for Parkinson’s disease. Advanced motion stimulation therapies, such as functional stimulation and therapeutic electric stimulation, are also commonly used to improve outcomes and speed up recovery from muscular dysfunction. These therapies make use of devices that use electric impulses to electrically stimulate and contract muscles. Which are Some Prominent Drivers Spearheading Motion stimulation therapy Market Growth? The increasing prevalence of Parkinson’s disease is the primary factor driving the growth of the motion stimulation market. The rising number of traffic accidents and muscle injuries is expected to propel the motion stimulation therapy market forward. Motion stimulation therapy can also be used in conjunction with conventional medicine. This is known as combination therapy, and the ability to use motion stimulation therapy as an add-on therapy is expected to drive market growth in the motion stimulation therapy market. Technological advancements in stimulator devices are also aiding in the expansion of the motion stimulation therapy market. Because of increased government funding for the development of novel drugs, the global Motion Stimulation Therapy market is expected to grow significantly during the forecast period. Each year, nearly 60,000 people in the United States are diagnosed with Parkinson’s disease, with an estimated 10 million people worldwide living with the disease, according to the Parkinson’s Association of the Carolinas. The functional neuromuscular stimulation therapy segment is expected to gain the most market share in the global motion stimulation therapy market due to the rising prevalence of Parkinson’s disease worldwide. Due to an increase in the number of patients seeking motion stimulation therapy, hospitals are expected to be the most dominant end-user segment. Talk to our Analyst for Further Assistance: How is North America Contributing to the Growth of the Motion stimulation therapy Market? Because of rising musculoskeletal disorders and increased fitness awareness, the motion stimulation therapy market in North America is expected to grow at a CAGR of 4.8 percent during the forecast period. The World Health Organization (WHO), for example, reported in February 2021 that approximately 1.71 billion people worldwide suffer from musculoskeletal disorders. The North American region is well-positioned to reign supreme in the global muscle stimulation devices market due to high spending on healthcare products, favourable reimbursement policies, and increased adoption among sedentary consumers. Key Companies Profiled: Valencia CA USA, , Cyberonics, , Medtronic, , Innovative Neurotronics Inc., , Boston Scientific Corporation, , Bioness Inc., , St. Jude Medical Inc., , Nevro Corporation Report Scope Market Competition Valencia, CA, USA, Cyberonics, Medtronic, Innovative Neurotronics, Inc. Boston Scientific Corporation; Bioness Inc. St. Jude Medical; Inc., and Nevro Corporation are some of the key players found across the value chain of motion Stimulation therapy market. Because of the large number of participants, the market is extremely competitive. Key Segments Covered in the Motion Stimulation Therapy Market Study Motion Stimulation Therapy Market by Therapy Type: Functional Neuromuscular Motion Stimulation Therapy Peripheral Motion Stimulation Therapy Therapeutic Electrical Motion Stimulation Therapy Motion Stimulation Therapy Market by End User: Motion Stimulation Therapy across Hospitals Motion Stimulation Therapy across Specialty Clinics Motion Stimulation Therapy across Other End User North America Motion Stimulation Therapy Market Latin America Motion Stimulation Therapy Market Western Europe Motion Stimulation Therapy Market Eastern Europe Motion Stimulation Therapy Market Asia Pacific excluding China & Japan Motion Stimulation Therapy Market China Motion Stimulation Therapy Market Japan Motion Stimulation Therapy Market Middle East and Africa Motion Stimulation Therapy Market About Future Market Insights (FMI)  Future Market Insights  (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years. Contact:

Bioness Frequently Asked Questions (FAQ)

  • Where is Bioness's headquarters?

    Bioness's headquarters is located at 25103 Rye Canyon Loop, Valencia.

  • What is Bioness's latest funding round?

    Bioness's latest funding round is Acquired.

  • How much did Bioness raise?

    Bioness raised a total of $3.5M.

  • Who are the investors of Bioness?

    Investors of Bioness include Bioventus, Paycheck Protection Program, GlenRock Israel and Teuza.

  • Who are Bioness's competitors?

    Competitors of Bioness include NeuroPace, Embolx, eSight, Affectiva, NeuroSky, Synapse Biomedical, Freedom Scientific, Spinal Modulation, CreatiVasc Medical, Corpora Systems and 23 more.

Compare Bioness to Competitors

SpineAlign Medical

Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.


SpineForm is developing a less invasive spinal deformity surgical treatment. SpineForm's HemiBridge is a spinal implant designed to help correct and straighten spinal deformities in growing children, without the need for a brace or extensive future spinal fusion surgeries.

Freedom Wand

Freedom Wand aims to offer a technology to bring freedom to those with limited mobility.

Embolx Logo

Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures. The Sniper balloon occlusion microcatheter aims to set a new standard for precise embolic delivery and target filling by controlling pressure to direct blood flow while protecting non-target surrounding tissues. The company was founded in 2013 and is based in Sunnyvale, California.

NDO Surgical

Medical devices for the treatment of severe gastrointestinal disorders

Proneuron Biotechnologies

Biopharmaceutical products for the of spinal cord injuries and other central nervous system disorders.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.